Skip to main content

Table 2 Comparison of clinical presentation, coronary lesion characteristics, and stent types between two longitudinal cohorts

From: Changes of antithrombotic prescription in atrial fibrillation patients with acute coronary syndrome or percutaneous coronary intervention and the subsequent impact on long-term outcomes: a longitudinal cohort study

Characteristics

Overall population (N=121)

P value

Cohort 1 ( N =35)

Cohort 2 ( N =86)

Clinical presentation

ACS presentation, N (%)

13 (37.1)

33 (38.4)

0.899

Coronary lesion characteristics

LM lesion, N (%)

3 (2.3)

5 (5.7)

0.421

LAD lesion, N (%)

35 (100.0)

77 (89.5)

0.041

LCX lesion, N (%)

24 (68.6)

54 (62.8)

0.547

RCA, N (%)

28 (80.0)

61 (70.9)

0.305

Stent placement, N (%)

30 (85.7)

77 (89.5)

0.544

Stent types

DES, N (%)*

18 (51.4)

53 (61.6)

0.302

BMS, N (%)

13 (37.1)

23 (26.7)

0.257

BVS, N (%)

1 (2.9)

1 (1.2)

0.497

  1. ACS, acute coronary syndrome; LM, left main coronary artery; LAD, left anterior descending artery; LCX, left circumflex artery; RCA, right coronary artery; DES, drug-eluting stent, BMS, bare-metal stent; BVS, bioresorbable scaffold
  2. * Two patients received both drug-eluting stent and bare-metal stent placement during the same procedure in cohort 1